Megevand Angelique, Ingles Jodie, Richmond David R, Semsarian Christopher
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
Am J Cardiol. 2005 Apr 15;95(8):991-3. doi: 10.1016/j.amjcard.2004.12.045.
In this study, patients with obstructive hypertrophic cardiomyopathy (HC) were treated with dual-chamber pacemaker therapy. Long-term follow-up analysis showed that dual-chamber pacemaker therapy in selected patients resulted in a significant reduction in symptoms and in the left ventricular outflow tract gradient, which was maintained up to 10 years after implantation. Dual-chamber pacing is of potential long-term benefit in selected groups of patients with obstructive HC.
